These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 20975615)
1. The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virus-infected children. Taweesith W; Puthanakit T; Kowitdamrong E; Bunupuradah T; Wongngam W; Phasomsap C; Apornpong T; Bouko C; Pancharoen C Pediatr Infect Dis J; 2011 Apr; 30(4):320-4. PubMed ID: 20975615 [TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1. Armenian SH; Han JY; Dunaway TM; Church JA Pediatr Infect Dis J; 2006 Apr; 25(4):368-70. PubMed ID: 16567993 [TBL] [Abstract][Full Text] [Related]
3. A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella. Gershon AA; Levin MJ; Weinberg A; Song LY; LaRussa PS; Steinberg SP; Bartlett P; Pediatr Infect Dis J; 2009 Jul; 28(7):653-5. PubMed ID: 19561431 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers. Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071 [TBL] [Abstract][Full Text] [Related]
5. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells. Levin MJ; Gershon AA; Weinberg A; Song LY; Fentin T; Nowak B; J Infect Dis; 2006 Jul; 194(2):247-55. PubMed ID: 16779732 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of postexposure immunization with live attenuated varicella vaccine in the household setting--a pilot study. Mor M; Harel L; Kahan E; Amir J Vaccine; 2004 Dec; 23(3):325-8. PubMed ID: 15530676 [TBL] [Abstract][Full Text] [Related]
8. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I; Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179 [TBL] [Abstract][Full Text] [Related]
9. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection. Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077 [TBL] [Abstract][Full Text] [Related]
10. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. Hardy I; Gershon AA; Steinberg SP; LaRussa P N Engl J Med; 1991 Nov; 325(22):1545-50. PubMed ID: 1658650 [TBL] [Abstract][Full Text] [Related]
11. Safety, Reactogenicity, and Immunogenicity of Human Rotavirus Vaccine RIX4414 in Human Immunodeficiency Virus-positive Infants in South Africa. Steele AD; Madhi SA; Louw CE; Bos P; Tumbo JM; Werner CM; Bicer C; De Vos B; Delem A; Han HH Pediatr Infect Dis J; 2011 Feb; 30(2):125-30. PubMed ID: 20842070 [TBL] [Abstract][Full Text] [Related]
12. Varicella vaccination in HIV-1-infected children after immune reconstitution. Bekker V; Westerlaken GH; Scherpbier H; Alders S; Zaaijer H; van Baarle D; Kuijpers T AIDS; 2006 Nov; 20(18):2321-9. PubMed ID: 17117018 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years. Vesikari T; Baer M; Willems P Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial. Pan HX; Qiu LX; Liang Q; Chen Z; Zhang ML; Liu S; Zhong GH; Zhu KX; Liao MJ; Hu JL; Li JX; Xu JB; Fan Y; Huang Y; Su YY; Huang SJ; Wang W; Han JL; Jia JZ; Zhu H; Cheng T; Ye XZ; Li CG; Wu T; Zhu FC; Zhang J; Xia NS Lancet Infect Dis; 2024 Aug; 24(8):922-934. PubMed ID: 38614117 [TBL] [Abstract][Full Text] [Related]
15. Study of tolerance and effectiveness of a varicella vaccine in leukemic children. Bancillon A; Leblanc T; Baruchel A; Schaison G; Leverger G; Mallarmey D; Teuliere L Nouv Rev Fr Hematol (1978); 1991; 33(6):555-6. PubMed ID: 1667953 [TBL] [Abstract][Full Text] [Related]
16. The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection. Hammond O; Wang Y; Green T; Antonello J; Kuhn R; Motley C; Stump P; Rich B; Chirmule N; Marchese RD J Med Virol; 2006 Dec; 78(12):1679-87. PubMed ID: 17063506 [TBL] [Abstract][Full Text] [Related]
17. Live attenuated varicella vaccine use in immunocompromised children and adults. Gershon AA; Steinberg SP; Gelb L Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495 [TBL] [Abstract][Full Text] [Related]
18. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule. American Academy of Pediatrics Committee on Infectious Diseases Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582 [TBL] [Abstract][Full Text] [Related]
19. Prevention and treatment of VZV infections in patients with HIV. Gershon AA Herpes; 2001 Jul; 8(2):32-6. PubMed ID: 11867015 [TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age. Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM; Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]